SA
Sher Ali Butt
Precision fermentation pioneer in cannabis, psychedelics, food, and beauty
San Diego, California
Overview
Sher Ali Butt is a Precision fermentation pioneer with a background in cannabis, psychedelics, food, and beauty industries, currently serving as the CoFounder, CEO, and Board Member at CB Therapeutics in San Diego, California. With a notable career trajectory that includes leadership roles at Y Combinator and Novartis, Sher Ali Butt has demonstrated expertise in biotechnology and strategic planning, contributing to the success and growth of various organizations within the biotech and consumer health sectors.
Work Experience
CoFounder, CEO, & Board Member
2015 - Current
Biotechnology pioneer in psychedelics, food tech, and cannabinoids; Y Combinator S '18 Batch
CB Therapeutics is a biotech company that specializes in the biosynthetic production of cannabinoids from sugar.
Raised $7,620,000.00 from Mystic Ventures.
Board Member
2021
Joint venture between atai Life Sciences (NASDAQ: ATAI) & CB Therapeutics
Venture Partner
2020
VC fund focused on top tier YC companies
CEO CB Therapeutics
2018 - 2018
Number one startup accelerator in the world
Team Lead/Associate
2016 - 2016
VC fund focused on UCSD startups
CoFounder/Chief Scientific Officer
2015 - 2016
Started a cannabis testing lab from scratch in 2.5 months. www.cblabs.us
CB Labs provides cannabis lab testing, research, and development testing services.
Senior Operations Manager
2013 - 2015
Naturalena Brands is an online shop that delivers baby diapers, wipes, feminine hygiene, natural baby care and incontinence products.
Senior Research Associate/Project Manager
2012 - 2013
Lab Director
2010 - 2011